News
Summary: New research uncovers how tau pathology spreads and damages synapses in progressive supranuclear palsy (PSP). Using ...
Progressive supranuclear palsy progresses much faster than Parkinson’s disease. It’s also less responsive to medications, such as levodopa, than Parkinson’s.
Progressive supranuclear palsy (PSP) causes profound and irreversible damage to the brain, often before a diagnosis is even made. Unlike ALS or Parkinson’s, PSP gradually affects balance, eyesight, ...
FNP-223, previously known as ASN90, is a reversible and substrate-competitive O-GlcNAcase enzyme inhibitor. The oral investigational drug is expected to rapidly increase O-GlcNAcylated tau proteins, ...
Progressive supranuclear palsy (PSP) was distinguished from Parkinson’s disease in 1963 as the “Steele-Richardson-Olszewski syndrome”. It is a progressive condition that usually shows onset ...
Progressive supranuclear palsy (PSP) is a rare brain disorder. It causes serious and permanent problems with control of gait (walking) and balance. The most obvious sign of the disease is when you can ...
PSP progressive supranuclear palsy, PD Parkinson's disease, HOA healthy older adult, DS double support percentage of gait cycle, n/s not statistically significant. Tables. Table 2.
Wexton said she has been diagnosed with progressive supranuclear palsy. Instagram/Rep. Jennifer Wexton. But PSP is said to worsen more rapidly than Parkinson’s and fewer treatment options are ...
DUBLIN--(BUSINESS WIRE)--The "Progressive Supranuclear Palsy - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. This report offers comprehensive Insight ...
LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the progressive supranuclear palsy market. The report includes a detailed analysis of the pipeline ...
Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "Progressive Supranuclear Palsy: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven ...
Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It causes muscle weakness and affects gait, balance and overall movement, as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results